Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Extreme Networks buy BiotechBee

Start price
€30.15
14.08.23 / 60%
Target price
€45.00
31.08.25
Performance (%)
-24.34%
End price
€22.81
01.10.23
Summary
This prediction ended on 01.10.23 with a price of €22.81. The prediction for Extreme Networks disappointed with a performance of -24.34%. BiotechBee has 60% into this prediction

Extreme Networks (EXTR) is a publicly listed company that provides comprehensive software-driven networking solutions for enterprise customers. The company designs, develops, and sells networking equipment, software, and services to create seamless experiences for its customers. It offers various products such as switches, routers, and wireless access points that are used by businesses and organizations to establish connectivity and network infrastructure. Extreme Networks focuses mainly on technology, education, healthcare, and hospitality markets, serving customers across the globe through its network of distributors, resellers, and partners.

Performance without dividends (%)
Name 1w 1m
Extreme Networks 6.152% 6.152%
iShares Core DAX® -1.347% 3.576%
iShares Nasdaq 100 1.169% 7.020%
iShares Nikkei 225® -0.327% -0.673%
iShares S&P 500 0.510% 4.445%

According to BiotechBee what are the pros and cons of Extreme Networks for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Extreme Networks diskutieren
Prediction Buy
Perf. (%) -24.34%
Target price 45.000
Change
Ends at 31.08.25

Buy mit Kursziel 45,0

In the thread Trading Extreme Networks
Prediction Buy
Perf. (%) -24.34%
Target price 45.000
Change
Ends at 31.08.25

Buy beendet